TY  - GEN
AU  - Reich,K
AU  - Pinter,A
AU  - Lacour,J P
AU  - Ferrandiz,C
AU  - Micali,G
AU  - French,L E
AU  - Lomaga,M
AU  - Dutronc,Y
AU  - Henneges,C
AU  - Wilhelm,S
AU  - Hartz,S
AU  - Paul,C
TI  - Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study
SN  - 1365-2133
PY  - 2018///0618
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Male
KW  - Patient Reported Outcome Measures
KW  - Psoriasis
KW  - drug therapy
KW  - Treatment Outcome
KW  - Ustekinumab
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1111/bjd.15666
ER  -